Moreover, reperfusion for ischemic stroke patients is mainly achieved by tissue plasminogen activator (t-PA) application for dissolving the clot with a limitation of a 3 h therapeutic time window after stroke [14], and its application is complicated increasing hemorrhage and aggravated ischemic injury [15]. Here, PLAT is linked to ischemic stroke.